Pentixapharm has brought in almost 20 mil | Pentixapharm has brought in almost 20 million euros ($22 million) from an IPO, with the German biotech earmarking the proceeds to push ahead with the clinical development of its two lead radiopharmaceuticals.
Pentixapharm scores $22M in Frankfurt IPO to advance clinical-stage radiopharmaceuticals
Date:
More like thisRelated
Tampa RV giant Lazydays to delist from Nasdaq
Tampa-based Lazydays Holdings Inc., one of Florida’s most recognized...
Granite Geek: New Hampshire might get access to ‘balcony solar’
I had solar panels put on my roof six...
TSX Today: What to Watch for in Stocks on Monday, November 10
Despite firm gold and silver prices, Canadian stocks...
While BNB and DOT Struggle Under Market Pressure, BlockDAG’s Presale Soars Past $435M!
As market-wide fear grips the sector, the Binance Coin...